Randomized, double-blind, placebo-controlled and active-controlled study to assess the relative abuse potential of oxycodone HCl-niacin tablets compared with oxycodone alone in nondependent, recreational opioid users.

Webster, Lynn R; Rolleri, Robert L; Pixton, Glenn C; Sommerville, Kenneth W

Webster, Lynn R; Rolleri, Robert L; Pixton, Glenn C; Sommerville, Kenneth W.

Afiliación

Webster LR; Lifetree Clinical Research, Salt Lake City, UT, USA.
Rolleri RL; Salix Pharmaceuticals, Inc., Raleigh, NC, USA ; Pfizer Inc, Cary, NC, USA.
Pixton GC; Pfizer Inc, Cary, NC, USA.
Sommerville KW; Pfizer Inc, Cary, NC, USA.

Subst Abuse Rehabil ; 3: 101-13, 2012.

Article en En | MEDLINE | ID: mdl-24474870

Palabras clave

drug abuse; niacin; opioid; oxycodone

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Subst Abuse Rehabil Año: 2012 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google